AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $86,000 | +28.4% | 3,061 | +0.2% | 0.00% | – |
| Q2 2022 | $67,000 | -20.2% | 3,054 | +4.2% | 0.00% | – |
| Q1 2022 | $84,000 | +21.7% | 2,930 | +37.9% | 0.00% | – |
| Q4 2021 | $69,000 | -28.9% | 2,125 | +0.6% | 0.00% | – |
| Q3 2021 | $97,000 | -32.6% | 2,113 | -19.7% | 0.00% | – |
| Q2 2021 | $144,000 | +7100.0% | 2,630 | +5160.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -98.4% | 50 | -97.9% | 0.00% | – |
| Q2 2020 | $125,000 | +71.2% | 2,341 | +12.7% | 0.00% | – |
| Q1 2020 | $73,000 | -88.9% | 2,078 | -85.5% | 0.00% | -100.0% |
| Q4 2018 | $659,000 | -40.2% | 14,300 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $1,102,000 | -73.3% | 14,300 | -70.9% | 0.00% | -71.4% |
| Q2 2018 | $4,134,000 | +77.2% | 49,087 | +72.0% | 0.01% | +75.0% |
| Q1 2018 | $2,333,000 | +4.3% | 28,532 | -27.1% | 0.00% | 0.0% |
| Q4 2017 | $2,237,000 | -36.3% | 39,136 | -25.7% | 0.00% | -33.3% |
| Q3 2017 | $3,514,000 | +131.8% | 52,659 | +78.6% | 0.01% | +100.0% |
| Q2 2017 | $1,516,000 | – | 29,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |